February 15-17, 2024  •  Hilton Midtown  •  New York, NY

Metabolic Syndrome & the Microbiome: Core Therapeutics for a Common Condition

Sponsored Morning Symposia

Metabolic Syndrome & the Microbiome: Core Therapeutics for a Common Condition.

Friday, February 16
7:30am – 8:30am

Let’s not sugarcoat it: Metabolic syndrome and insulin resistance affect over 30% of the adult population in the US. Understanding the significant role the gut microbiome plays in regulating blood sugar and metabolism is key to helping patients successfully deal with this common condition.

Join Dr. Jocelyn Strand, ND, Director of Clinical Education and Research at Biocidin Botanicals, as she shares the latest science – and her own clinical experience – related to the microbiome and blood-sugar regulation.

Learning Objective #1: How the gut microbiome influences satiety, gut barrier integrity, and insulin resistance

Learning Objective #2: Novel therapeutic targets that may restore gut microbiome health

Learning Objective #3: How a healthy microbiome helps to prevent obesity

Untitled design (88)


Jocelyn Stand, ND

Jocelyn Strand, ND, is Director of Clinical Education and Research for Biocidin Botanicals. She brings both a reverence for botanicals and a passion for science to her role.

Dr. Strand monitors and participates in research, trains clinicians, and is a respected and engaging speaker. Before joining Biocidin Botanicals in 2019, Dr. Strand was a primary care provider in private practice for 11 years through the Minnesota Board of Medical Practice. She specialized in GI system disorders, Lyme disease, and autoimmune conditions.

© Diversified Communications. All rights reserved.